HOB Biotech Group Corp.,Ltd (688656.SS)
CNY 97.15
(-1.95%)
CNY 97.15
(-1.95%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 949.25 Million CNY | 0.5% |
| 2022 | 944.55 Million CNY | 9.33% |
| 2021 | 863.91 Million CNY | 191.46% |
| 2020 | 296.41 Million CNY | 4.67% |
| 2019 | 283.17 Million CNY | 25.73% |
| 2018 | 225.22 Million CNY | 56.16% |
| 2017 | 144.22 Million CNY | 15.7% |
| 2016 | 124.65 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 1 Billion CNY | 1.58% |
| 2024 Q1 | 977.99 Million CNY | 3.03% |
| 2024 Q2 | 987.27 Million CNY | 0.95% |
| 2023 Q3 | 953.83 Million CNY | 2.56% |
| 2023 FY | 949.25 Million CNY | 0.5% |
| 2023 Q1 | 925.97 Million CNY | -1.97% |
| 2023 Q4 | 949.25 Million CNY | -0.48% |
| 2023 Q2 | 929.99 Million CNY | 0.43% |
| 2022 Q4 | 944.55 Million CNY | 6.09% |
| 2022 Q3 | 890.31 Million CNY | 2.71% |
| 2022 Q2 | 866.79 Million CNY | -0.94% |
| 2022 Q1 | 875.01 Million CNY | 1.28% |
| 2022 FY | 944.55 Million CNY | 9.33% |
| 2021 Q1 | 783.13 Million CNY | 164.21% |
| 2021 Q2 | 799.52 Million CNY | 2.09% |
| 2021 FY | 863.91 Million CNY | 191.46% |
| 2021 Q4 | 863.91 Million CNY | 2.74% |
| 2021 Q3 | 840.84 Million CNY | 5.17% |
| 2020 FY | 296.41 Million CNY | 4.67% |
| 2020 Q4 | 296.41 Million CNY | 14.4% |
| 2020 Q3 | 259.1 Million CNY | 9.32% |
| 2020 Q2 | 237.01 Million CNY | -12.68% |
| 2020 Q1 | 271.42 Million CNY | -4.15% |
| 2019 Q4 | 283.17 Million CNY | 0.0% |
| 2019 FY | 283.17 Million CNY | 25.73% |
| 2018 FY | 225.22 Million CNY | 56.16% |
| 2017 FY | 144.22 Million CNY | 15.7% |
| 2016 FY | 124.65 Million CNY | 0.0% |